View in EDS HTML Full Text PDF Full Text

Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma.

Saved in:
Bibliographic Details
Title: Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma.
Authors: Maas CCHM; Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands. c.h.m.maas@erasmusmc.nl.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. c.h.m.maas@erasmusmc.nl., van Klaveren D; Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands., Durmaz M; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Amsterdam UMC, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands., Visser O; Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Issa DE; Department of Internal Medicine, Jeroen Bosch Hospital, Den Bosch, The Netherlands., Posthuma EFM; Department of Internal Medicine, Reinier de Graaf Gasthuis, Delft, The Netherlands.; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Zijlstra JM; Amsterdam UMC, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands., Chamuleau MED; Amsterdam UMC, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands., Lugtenburg PJ; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Hematology, Rotterdam, The Netherlands., Kersten MJ; Amsterdam UMC, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands., Dinmohamed AG; Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands. a.dinmohamed@iknl.nl.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. a.dinmohamed@iknl.nl.; Amsterdam UMC, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands. a.dinmohamed@iknl.nl.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands. a.dinmohamed@iknl.nl.
Source: Blood cancer journal [Blood Cancer J] 2024 Sep 12; Vol. 14 (1), pp. 157. Date of Electronic Publication: 2024 Sep 12.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39266543
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Maas+CCHM%22">Maas CCHM</searchLink>; Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands. c.h.m.maas@erasmusmc.nl.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. c.h.m.maas@erasmusmc.nl.<br /><searchLink fieldCode="AU" term="%22van+Klaveren+D%22">van Klaveren D</searchLink>; Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Durmaz+M%22">Durmaz M</searchLink>; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Amsterdam UMC, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Visser+O%22">Visser O</searchLink>; Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Issa+DE%22">Issa DE</searchLink>; Department of Internal Medicine, Jeroen Bosch Hospital, Den Bosch, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Posthuma+EFM%22">Posthuma EFM</searchLink>; Department of Internal Medicine, Reinier de Graaf Gasthuis, Delft, The Netherlands.; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Zijlstra+JM%22">Zijlstra JM</searchLink>; Amsterdam UMC, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Chamuleau+MED%22">Chamuleau MED</searchLink>; Amsterdam UMC, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Lugtenburg+PJ%22">Lugtenburg PJ</searchLink>; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Hematology, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kersten+MJ%22">Kersten MJ</searchLink>; Amsterdam UMC, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Dinmohamed+AG%22">Dinmohamed AG</searchLink>; Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands. a.dinmohamed@iknl.nl.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. a.dinmohamed@iknl.nl.; Amsterdam UMC, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands. a.dinmohamed@iknl.nl.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands. a.dinmohamed@iknl.nl.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2024 Sep 12; Vol. 14 (1), pp. 157. <i>Date of Electronic Publication: </i>2024 Sep 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39266543
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-024-01137-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 157
    Titles:
      – TitleFull: Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Maas CCHM
      – PersonEntity:
          Name:
            NameFull: van Klaveren D
      – PersonEntity:
          Name:
            NameFull: Durmaz M
      – PersonEntity:
          Name:
            NameFull: Visser O
      – PersonEntity:
          Name:
            NameFull: Issa DE
      – PersonEntity:
          Name:
            NameFull: Posthuma EFM
      – PersonEntity:
          Name:
            NameFull: Zijlstra JM
      – PersonEntity:
          Name:
            NameFull: Chamuleau MED
      – PersonEntity:
          Name:
            NameFull: Lugtenburg PJ
      – PersonEntity:
          Name:
            NameFull: Kersten MJ
      – PersonEntity:
          Name:
            NameFull: Dinmohamed AG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 09
              Text: 2024 Sep 12
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1